Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of V710 in Adults With Kidney Disease on Hemodialysis (V710-005)(COMPLETED) [Phase 2]

View source ↗

Summary

This Phase 2 trial assessed the safety and immunogenicity of Merck's V710 vaccine in adults with kidney disease on hemodialysis and has completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Infection

Drugs mentioned

• V710 (V710 vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Staphylococcus Aureus Infection | Phase 2 | Status: COMPLETED | Results posted: 2011-08-15